No Detail Found!

A herbal treatment approach for the management of clinical, hormonal and ultrasound parameters in reproductive age group women with polycystic ovarian syndrome: A randomized clinical trial

Author(s)
Sumira Ishaq Department of Pharmacognosy, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
Ghazala H Rizwani Research Department, Hamdard University, Karachi, Pakistan
Huma Shareef Department of Pharmacognosy, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
Sakina Fatima Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
Humaira Anser Department of Pharmacology, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
Sana Sarfraz Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Abstract
Around fifteen percent women of reproductive age have been effected by Polycystic Ovarian Syndrome (PCOS); a complicated disorder; and apparently there is no standard therapy available. Considering this lack, we design present work; for the assessment of a herbal medicine (Femitex-SP4) in managing PCOs. During 2016-17; this study was carried out at Abbasi Shaheed hospital, Karachi, Pakistan. A total of 150 patients aged between 18-44 years were included as per Rotterdam criteria. Patients received 500 mg of powdered herbs in capsule form twice daily. The primary outcomes were regular menstruation and ovulation plus change in fasting blood sugar levels. Changes in free testosterone levels and ovarian morphology was secondary outcome measures. Continuous outcomes before and after treatment were compared by Student's t-test (one tailed, independent). P = 0.05 was considered as significant. Women menstrual cycle was considerably improved. Fasting blood sugar levels did not change (p=0.103392). Progesterone levels were same at the starting point and after treatment (P=0.318322). With complete recovery in 6 patients; a notable change was found in ovarian size. Free testosterone levels were also dropped significantly (p<0.00001). Our main success was drastic improvement in normalizing menstrual cycle during therapy. Herbal treatment is proven to be clinically effective in most of the patients; particularly PCOs patients with menstrual irregularities. Hence, Femitex-SP4 can be taken as a better treatment for PCOs.
Publication Details
Page(s) 1097-1102
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP3, Year: 2021

Request the full text from PASTIC

Keywords
PCOS, fasting blood sugar, Progesterone, menstrual cycle, ovarian size
References
Ching H,Burke V,Stuckey B .2007 .Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. J. Clin. Endocrinol. Metab., 66(3) : 373-379.
TT and Group ESHRE,A-SPCW ESHRE .2008 .Consensus on infertility treatment related to polycystic ovary syndrome. Fertil, 89(3) : 505-522.
Francis G,Kerem Z,Makkar HP,Becker K HP .2002 .The biological action of saponins in animal systems: A review. Br. J. Nutr, 88(6) : 587-605.
Garad R,Teede HJ,Moran L HJ .2011 .An evidencebased guideline for polycystic ovary syndrome. Aust, 19(4) : 30.
Goyal A,Gupta JK,Garabadu D JK .2021 .Phytoestrogens are emerging medicine in prevention and management of cognitive deficits in postmenopausal women. Res. J. Pharm. Technol., 14(1) : 513-515.
Ramasamy S Grant P .2012 .An update on plant derived anti-androgens. Int. J. Endocrinol.Metab., 10(2) : 497.
Haerifar N,Vaezi G,Samani ZG,Lak SS,Holden S,Davis R,Yeh G .2014 .Pregnant women's use of complementary and alternative medicine in the United States. J. Altern. Complement. Med, 20(5) : A120-A120.
Ishaque S,Rizwani Gh,Shareef H,Gauhar S,Ahmed M,Khursheed R M .2011 .Formulation and pharmaceutical evaluation of polyherbal capsule (Femitex-SP4) for treating menorrhagi A. Int. J. Pharm Pharm Sci., 3(5) : 149-154.
Kamel HH .2013 .Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. Eur. J. Obstet. Gynecol., 168(1) : 60-63.
Kapoor MP,Suzuki K,Derek T,Ozeki M,Okubo T .2020 .Clinical evaluation of Emblica officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, doubleblind, crossover placebo-controlled study. Contemp. Clin. Trials Commun, 17 : 100499.
Khani B,Mehrabian F,Khalesi E,Eshraghi A .2011 .Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome. J. Res. Med. Sci., 16(3) : 297.
Kousta E,White D,Franks S D .1997 .Modern use of clomiphene citrate in induction of ovulation. Hum. Reprod. Update., 3, (4) : 359-365.
Lauritzen C,Reuter H,Repges R,Bohnert KJ,Schmidt U .1997 .Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine, 4(3) : 183-189.
Legro RS,Arslanian SA,Ehrmann DA,Hoeger KM,Murad MH,Pasquali R,Welt CK,Endocrine Society CK .2014 .Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. Reproduc. Endocrinol., 20 : 22-35.
Lunny CA,Fraser SN .2010 .The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women. J. Midwifery Womens Health, 55(4) : 335-343.
Macut D,Pfeifer M,Yildiz BO,Diamanti-Kandarakis E .2013 .Polycystic ovary syndrome novel insights into causes and therapy preface: KARGER POSTFACH. , : .
Marshall JC,Dunaif A .2012 .Should all women with PCOS be treated for insulin resistance? Fertil. , 97(1) : 18-22.
Messinis IE .2005 .Ovulation induction: A mini review. Hum. Reprod., 20(10) : 2688-2697.
Mohan BS .2005 .Mid-luteal phase plasma progesterone levels in spontaneous and clomiphene citrate induced conception cycles. J. Obstet. Gynaecol. India., 55(4) : 350-352.
Pachiappan S,Ramalingam K,Balasubramanian A .2020 .A review on phytomedicine and their mechanism of action on PCOS. Int. J. Cur. Res. Rev, 12(23) : 81.
Pankaj O .2003 .Chirai Jam (Syzygium cuminii) as a medicinal herb in Chhattisgarh. , : .
Polson DW,Kiddy DS,Mason HD,Franks S HD .1989 .Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and nonresponders. , 51(1) : 30-34.
Sharma P .1996 .Classical Uses of Medicinal Plants, Chaukhambha Vishvabharati. Oriental Publisher and Distributors, 66 : 67.
Sills ES,Perloe M,Tucker MJ,Kaplan CR,Genton MG,Schattman GL .2001 .Diagnostic and treatment characteristics of polycystic ovary syndrome: Descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Women's Health, 1(1) : 3.
Singh S,Krishna TA,Kamalraj S,Kuriakose GC,Valayil JM,Jayabaskaran C JM .2015 .Phytomedicinal importance of Saraca asoca (Ashoka): An exciting past, an emerging present and a promising future. Curr. Sci., : 1790-1801.
Sivarajan V,Balachandran I .1994 .Ayurvedic drugs and their plant sources: Oxford and. , : .
Tang T,Glanville J,Hayden CJ,White D,Barth JH,Balen AH .2005 .Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, doubleblind multicentre study. Hum. Reprod., 21(1) : 80-89.
Thatcher SS .2000 .PCOS (polycystic Ovary Syndrome): The Hidden Epidemic. , : .
Whitten PL,Naftolin F PL .1998 .Reproductive actions of phytoestrogens. Baillieres Clin. Endocrinol. Metab, 12(4) : 667-690.
Wolff MS,Teitelbaum SL,Pinney SM,Windham G,Liao L,Biro F,Kushi LH,Erdmann C,Hiatt RA,Calafat AM .2010 .Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates and phenols and pubertal stages in girls. Environ. Health Perspect, 118(7) : 1039-1046.
Yadav K,Ghadge P,Langeh A,Kalbhare S,Phadtare P,Bhoite R .2020 .A Review on Herbal Medicinal Plant for Treatment of Polycystic Ovarian Syndrome (PCOS). AJPRD., 8(4) : 83-87.
0

Citations

0

Downloads

9

Views